Form 4: TTM Technologies Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
TTM Technologies Director Thomas T. Edman sold 16,800 shares of common stock for $101.62 per share under a pre-arranged 10b5-1 plan.
Summary
- Thomas T. Edman, a Director of TTM Technologies Inc. (TTMI), sold 16,800 shares of common stock.
- The transaction occurred on March 2, 2026, at a price of $101.62 per share.
- The sale was executed pursuant to a Rule 10b5-1 sales plan.
- Following this transaction, Mr. Edman beneficially owns 855,171 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. While insider selling can sometimes be a negative signal, the execution under a 10b5-1 plan suggests a pre-planned financial management decision rather than a reaction to new adverse company-specific information.
Negatives
- A Director of TTM Technologies Inc. sold 16,800 shares of company common stock.
Future Outlook
No forward-looking statements or guidance are provided in this insider transaction report.
Industry Context
StockSavvy.ai notes that insider sales, even under 10b5-1 plans, are routinely monitored by investors for potential signals regarding management's confidence in future company performance or valuation. This is a standard disclosure for director transactions.
Stakeholder Impact
- Shareholders: May interpret the sale as a slight negative signal, though mitigated by the 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 03/02/2026 | Date of transaction (sale of common stock) |
| 03/03/2026 | Signature date of the reporting person's attorney-in-fact |
Recommendation
holdThe sale by a director, while a disposition of shares, was executed under a pre-arranged 10b5-1 plan, which typically indicates personal financial planning rather than a lack of confidence in the company's future. This single transaction does not provide sufficient new information to alter an investment thesis, thus a 'hold' recommendation is appropriate.
Keywords
TTM Technologies, TTMI, Form 4, insider trading, director, stock sale, 10b5-1 plan, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.